New: Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia

Sponsor
Tjhin Wiguna (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04343664
Collaborator
Fakultas Kedokteran Universitas Indonesia (Other)
10,000
1
10.9
914

Study Details

Study Description

Brief Summary

The Covid-19 pandemic in Indonesia makes several changes in daily living. The Indonesian government suggests that everyone should stay at home by implements the work from home and school from home. Therefore, the issues related with Covid-19 are also worrying such as death because of the infection, virus transmission, doing everything from home such as Friday praying for Moslem, Sunday service at home, etc. People is anxious whenever meeting people because they are not really understand whether people is infected or not. Therefore, this study tries to identify the impact of Covid-19 pandemic in Indonesia towards mental well-being of the community.

Detailed Description

The Covid-19 pandemic in Indonesia makes several changes in daily living. The Indonesian government suggests that everyone should stay at home by implements the work from home and school from home. Therefore, the issues related with Covid-19 are also worrying such as death because of the infection, virus transmission, doing everything from home such as Friday praying for Moslem, Sunday service at home, etc. People is anxious whenever meeting people because they are not really understand whether people is infected or not. Therefore, this study tries to identify the impact of Covid-19 pandemic in Indonesia towards mental well-being of the community. The aims of this study are trying to collect and identify the most important aspect of mental health that affected by the Covid-19 pandemic in Indonesia, and using this data we are trying to propose the exact mental health promotion and prevention program for the community. The study design is cross sectional. We develop the questionnaire that suitable for our study, consists of demographic data, life experience data. In addition, for assessing mental health problems, the study uses PHQ-9, SRQ-20, GAD-7, SDQ for children 4

  • 10 years old and 11 - 17 years old. The study is done by online survey. The data analysis is done by SPSS for mac version 21.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
10000 participants
Observational Model:
Ecologic or Community
Time Perspective:
Cross-Sectional
Official Title:
Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia
Anticipated Study Start Date :
Feb 1, 2021
Anticipated Primary Completion Date :
Nov 1, 2021
Anticipated Study Completion Date :
Dec 31, 2021

Outcome Measures

Primary Outcome Measures

  1. Depression [up to 5 minutes]

    The depression symptoms assessed by Patient Health Queationnaire-9 Scale. The range is 0 -27, the highest score means the highest depresive

  2. Anxiety symptoms [up to 5 minutes]

    The anxiety symptoms assessed by Generalized Anxiety Disorder -7 Scale. It is consists of 7 item with ranged score 0 -21. The highest score means the highest anxiety

  3. Stress related problems [up to 7 minutes]

    The stress related problems assessed by Self Reporting Questionnaire-20 Scale. The range is 0 -20, the highest score means the highest mental health problems

  4. Behavior and emotional problem among children and adolescents [up to 5 minutes]

    Behavior and emotional problem among children and adolescents assessed by Strength and Difficulties Questionnaire. SDQ consists of 25 statements, the score is ranged from 0 - 60. The highest score means the highest problems

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Willing to participate on this study by signing the informed consent
Exclusion Criteria:
  • No

Contacts and Locations

Locations

Site City State Country Postal Code
1 dr. Cipto Mangunkusumo General Hospital Jakarta Pusat DKI Jakarta Indonesia 10430

Sponsors and Collaborators

  • Tjhin Wiguna
  • Fakultas Kedokteran Universitas Indonesia

Investigators

  • Principal Investigator: Tjhin Wiguna, PhD, Dr Cipto Mangunkusumo General Hospital
  • Principal Investigator: Tjhin Wiguna, PhD, Fakultas Kedokteran Univeristas Indonesia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tjhin Wiguna, Prof. Dr. dr., Dr Cipto Mangunkusumo General Hospital
ClinicalTrials.gov Identifier:
NCT04343664
Other Study ID Numbers:
  • MH-Covid19
First Posted:
Apr 13, 2020
Last Update Posted:
Feb 9, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tjhin Wiguna, Prof. Dr. dr., Dr Cipto Mangunkusumo General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 9, 2021